Back
Adaptimmune Therapeutics PLC Stock Price Chart
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Sell
30
ADAP
Adaptimmune Therapeutics PLC
Last Price:
0.83
Seasonality Move:
40.93%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!- The current trend is relatively stagnant and ADAP is experiencing buying pressure, which is a positive indicator for future bullish movement.
Adaptimmune Therapeutics PLC Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.76 | Buy |
| 20-day SMA: | 0.81 | Buy |
| 50-day SMA: | 0.96 | Sell |
| 200-day SMA: | 1.13 | Sell |
| 8-day EMA: | 0.78 | Buy |
| 20-day EMA: | 0.82 | Buy |
| 50-day EMA: | 0.91 | Sell |
| 200-day EMA: | 1.03 | Sell |
Adaptimmune Therapeutics PLC Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 48.33 | Sell |
| Chaikin Money Flow: | 444283 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.76 - 0.9) | Sell |
| Bollinger Bands (100): | (0.87 - 1.21) | Sell |
Adaptimmune Therapeutics PLC Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Adaptimmune Therapeutics PLC Stock
Is Adaptimmune Therapeutics PLC Stock a Buy?
- Adaptimmune Therapeutics PLC share price is 0.83 while ADAP 8-day simple moving average is 0.76, which is a Buy signal.
- The stock price of ADAP is 0.83 while Adaptimmune Therapeutics PLC 20-day SMA is 0.81, which makes it a Buy.
- Adaptimmune Therapeutics PLC 50-day simple moving average is 0.96 while ADAP share price is 0.83, making it a Sell technically.
- ADAP stock price is 0.83 and Adaptimmune Therapeutics PLC 200-day simple moving average is 1.13, creating a Sell signal.
ADAP Technical Analysis vs Fundamental Analysis
Sell
30
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy or a Sell?
-
Adaptimmune Therapeutics PLC stock is rated a Sell
The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.83. The Score for ADAP is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Adaptimmune Therapeutics PLC Stock Info
Market Cap:
212.27M
Price in USD:
0.83
Share Volume:
444.28K
Adaptimmune Therapeutics PLC 52-Week Range
52-Week High:
2.05
52-Week Low:
0.42
Sell
30
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Adaptimmune Therapeutics PLC Share Price Forecast
-
What is the Adaptimmune Therapeutics PLC stock price today?
The Adaptimmune Therapeutics PLC stock price is 0.83 USD today. -
Will ADAP stock go up or go down?
Adaptimmune Therapeutics PLC> share price is forecast to RISE/FALL based on technical indicators -
Is Adaptimmune Therapeutics PLC overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Adaptimmune Therapeutics PLC is overvalued.
Is Adaptimmune Therapeutics PLC Stock a Buy?
- Adaptimmune Therapeutics PLC share price is 0.83 while ADAP 8-day exponential moving average is 0.78, which is a Buy signal.
- The stock price of ADAP is 0.83 while Adaptimmune Therapeutics PLC 20-day EMA is 0.82, which makes it a Buy.
- Adaptimmune Therapeutics PLC 50-day exponential moving average is 0.91 while ADAP share price is 0.83, making it a Sell technically.
- ADAP stock price is 0.83 and Adaptimmune Therapeutics PLC 200-day simple moving average is 1.03, creating a Sell signal.
Fundamental Analysis of Adaptimmune Therapeutics PLC
Is Adaptimmune Therapeutics PLC a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.34 per share.
Technical Analysis of Adaptimmune Therapeutics PLC
Should I short Adaptimmune Therapeutics PLC stock?
- ADAP Moving Average Covergence Divergence (MACD) indicator is -0.05, suggesting Adaptimmune Therapeutics PLC is a Sell
- Adaptimmune Therapeutics PLC Relative Strength Index (RSI) is 48.33, which suggest Adaptimmune Therapeutics PLC is oversold
- The Bollinger Bands (25) for Adaptimmune Therapeutics PLC is (0.76 - 0.9), which suggest Adaptimmune Therapeutics PLC is a Sell
- The Bollinger Bands (100) for Adaptimmune Therapeutics PLC is (0.87 - 1.21), which suggest Adaptimmune Therapeutics PLC is a Sell
* Adaptimmune Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.